# Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies

> **NCT05402397** · PHASE4 · COMPLETED · sponsor: **Hospital General de Niños Pedro de Elizalde** · enrollment: 40 (actual)

## Conditions studied

- Uric Acid Nephropathy

## Interventions

- **DRUG:** Losartan Potassium

## Key facts

- **NCT ID:** NCT05402397
- **Lead sponsor:** Hospital General de Niños Pedro de Elizalde
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-01-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05402397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05402397, "Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05402397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*